SCHEMBL5652145

SCHEMBL5652145

COCCOc1cc2ncnc(Nc3ccc(N(C)CCc4ccccc4)cc3C3=CC(=O)C=CC3=O)c2cc1OC

nearest known ligand 0.55

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
KDR P35968 20/20 0.55
EGFR P00533 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5649635 0.91 KDR (0.53) KDREGFR
SCHEMBL5653774 0.89 KDR (0.57) KDREGFR
SCHEMBL5651331 0.89 KDR (0.64) KDREGFR
SCHEMBL5650859 0.87 KDR (0.56) KDREGFR
SCHEMBL5652496 0.85 KDR (0.59) KDREGFR
SCHEMBL5649271 0.85 KDR (0.54) KDREGFR
SCHEMBL5651269 0.84 KDR (0.56) KDREGFR
SCHEMBL5651300 0.84 KDR (0.68) KDREGFR
SCHEMBL5650791 0.83 KDR (0.62) KDREGFR
SCHEMBL5654431 0.83 KDR (0.54) KDREGFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070299092-A1 Quinone Substituted Quinazoline and Quinoline Kinase Inhibitors WYETH (US) 2007-12-27 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070299092-A1 Quinone Substituted Quinazoline and Quinoline Kinase Inhibitors KDR, FLT1, FLT4 KDR 1/4885EGFR 439/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.